Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01826448
Brief Title: A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Melanoma

First Submitted : April 1, 2013
First Submitted that Met QC Criteria : April 3, 2013
First Posted : April 8, 2013 (Estimate)

Results First Submitted : May 12, 2020
Results First Submitted that Met QC Criteria : May 12, 2020
Results First Posted : May 28, 2020

Last Update Submitted that Met QC Criteria : May 12, 2020
Last Update Posted : May 28, 2020